Normal glucose homeostasis

Principles of Diabetes Mellitus

Volumn , Issue , 2010, Pages 19-35

  Shrayyef, Muhammad Z ^a   Gerich, John E ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84878642900     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-09841-8_2     Document Type: Chapter

References (97)

1. Rizza R, Gerich J, Haymond M, et al. Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, subcutaneous insulin infusion and intensified conventional insulin therapy. N Engl J Med. 1980;303:1313-1318.
2. Wahren J, Felig P, Hagenfeldt L. Physical exercise and fuel homeostasis in diabetes mellitus. Diabetologia. 1978;14:213-222.
3. Consoli A, Kennedy F, Miles J, Gerich J. Determination of Krebs cycle metabolic carbon exchange in vivo and its use to estimate the individual contributions of gluconeogenesis and glycogenolysis to overall glucose output in man. J Clin Invest. 1987;80:1303-1310.
4. Gerich J. Control of glycaemia. Baillieres Clin Endocrinol Metab. 1993;7:551-586.
5. Gerich J. Glucose counterregulation and its impact on diabetes mellitus. Diabetes. 1988;37:1608-1617.
6. Siesjo BK. Hypoglycemia, brain metabolism, and brain damage. Diabetes Metab Rev. 1988;4:113-144.
7. Owen O, Morgan A, Kemp H, Sullivan J, Herrera M, Cahill G. Brain metabolism during fasting. J Clin Invest. 1967;46: 1589-1595.
8. Mitrakou A, Ryan C, Veneman T, et al. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol. 1991;260:E67-E74.
9. Jarrett RJ, Keen H. Hyperglycaemia and diabetes mellitus. Lancet. 1976;2:1009-1012.
10. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care. 1999;22:920-924.
11. Tchobroutsky G. Relation of diabetic control to development of microvascular complications. Diabetologia. 1978;15:143-152.
12. Kelley D, Mitrakou A, Marsh H, et al. Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load. J Clin Invest. 1988;81:1563-1571.
13. Meyer C, Dostou J, Nadkarni V, Gerich J. Effects of physiological hyperinsulinemia on systemic, renal and hepatic substrate metabolism. Am J Physiol. 1998;275:F915-F921.
14. Oster-Jorgensen E, Pedersen SA, Larsen ML. The influence of induced hyperglycaemia on gastric emptying rate in healthy humans. Scand J Clin Lab Invest. 1990;50:831-836.
15. Meyer C, Nadkarni V, Stumvoll M, Gerich J. Human kidney free fatty acid and glucose uptake: evidence for a renal glucose-fatty acid cycle. Am J Physiol. 1997;273:E650-E654.
16. Gerich JE. Physiology of glucose homeostasis. Diabetes Obes Metab. 2000;2:345-350.
17. Stumvoll M, Mitrakou A, Pimenta W, et al. Assessment of insulin secretion from the oral glucose tolerance test in white patients with type 2 diabetes. Diabetes Care. 2000;23:1440-1441.
18. Woerle HJ, Meyer C, Dostou JM, et al. Pathways for glucose disposal after meal ingestion in humans. Am J Physiol Endocrinol Metab. 2003;284:E716-E725.
19. Gosmanov NR, Szoke E, Israelian Z, et al. Role of the decrement in intraislet insulin for the glucagon response to hypoglycemia in humans. Diabetes Care. 2005;28:1124-1131.
20. Bolli G, Gottesman I, Cryer P, Gerich J. Glucose counterregulation during prolonged hypoglycemia in normal humans. Am J Physiol. 1984;247:E206-E214.
21. Gromada J, Franklin I, Wollheim CB. Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains. Endocr Rev. 2007;28:84-116.
22. Magnusson I, Rothman D, Gerard D, Katz L, Shulman G. Contribution of hepatic glycogenolysis to glucose production in humans in response to a physiological increase in plasma glucagon concentration. Diabetes. 1995;44:185-189.
23. Gerich J. Physiology of glucagon. Int Rev Physiol. 1981;24:244-275.
24. Lecavalier L, Bolli G, Cryer P, Gerich J. Contributions of gluconeogenesis and glycogenolysis during glucose counterregulation in normal humans. Am J Physiol. 1989;256:E844-E851.
25. Gerich J, Cryer P, Rizza R. Hormonal mechanisms in acute glucose counterregulation: the relative roles of glucagon, epinephrine, norepinephrine, growth hormone and cortisol. Metabolism. 1980;29(Suppl 1):1164-1175.
26. Rizza R, Cryer P, Haymond M, Gerich J. Adrenergic mechanisms of catecholamine action on glucose homeostasis in man. Metabolism. 1980;29(Suppl):1155-1163.
27. Stumvoll M, Chintalapudi U, Perriello G, Welle S, Gutierrez O, Gerich J. Uptake and release of glucose by the human kidney: postabsorptive rates and responses to epinephrine. J Clin Invest. 1995;96:2528-2533.
28. DeFeo P, Perriello G, Torlone E, et al. Contribution of adrenergic mechanisms to glucose counterregulation in humans. Am J Physiol. 1991;261:E725-E736.
29. Rizza R, Mandarino L, Gerich J. Effects of growth hormone on insulin action in man: mechanisms of insulin resistance, impaired suppression of glucose production and impaired stimulation of glucose utilization. Diabetes. 1982;31:663-669.
30. DeFeo P, Perriello G, Torlone E, et al. Demonstration of a role of growth hormone in glucose counterregulation. Am J Physiol. 1989;256:E835-E843.
31. DeFeo P, Perriello G, Torlone E, et al. Contribution of cortisol to glucose counterregulation in humans. Am J Physiol. 1989;257:E35-E42.
32. Fanelli C, Calderone S, Epifano L, et al. Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans. J Clin Invest. 1993;92:1617-1622.
33. Cahill G. Starvation in man. N Engl J Med. 1970;282:668-675.
34. Havel R. Caloric homeostasis and disorders of fuel transport. N Engl J Med. 1972;287:1186-1192.
35. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes. 1997;46:3-10.
36. McGarry J. Glucose-fatty acid interactions in health and disease. Am J Clin Nutr. 1998;67(3 Suppl):500S-504S.
37. Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology. 2007;132:2131-2157.
38. Brown JC, Dryburgh JR, Ross SA, Dupre J. Identification and actions of gastric inhibitory polypeptide. Recent Prog Horm Res. 1975;31:487-532.
39. Nauck MA, Heimesaat MM, Behle K, et al. Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers. J Clin Endocrinol Metab. 2002;87:1239-1246.
40. Rayner CK, Samsom M, Jones KL, Horowitz M. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care. 2001;24:371-381.
41. Horowitz M, Edelbroek MA, Wishart JM, Straathof JW. Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects. Diabetologia. 1993;36:857-862.
42. Jones KL, Horowitz M, Carney BI, Wishart JM, Guha S, Green L. Gastric emptying in early noninsulin-dependent diabetes mellitus. J Nucl Med. 1996;37:1643-1648.
43. MacGregor IL, Gueller R, Watts HD, Meyer JH. The effect of acute hyperglycemia on gastric emptying in man. Gastroenterology. 1976;70:190-196.
44. Bjornsson ES, Urbanavicius V, Eliasson B, Attvall S, Smith U, Abrahamsson H. Effects of hyperglycemia on interdigestive gastrointestinal motility in humans. Scand J Gastroenterol. 1994;29:1096-1104.
45. Karamanlis A, Chaikomin R, Doran S, et al. Effects of protein on glycemic and incretin responses and gastric emptying after oral glucose in healthy subjects. Am J Clin Nutr. 2007;86:1364-1368.
46. Gentilcore D, Chaikomin R, Jones KL, et al. Effects of fat on gastric emptying of and the glycemic, insulin, and incretin responses to a carbohydrate meal in type 2 diabetes. J Clin Endocrinol Metab. 2006;91:2062-2067.
47. Mueckler M. Family of glucose-transporter genes implications for glucose homeostasis and diabetes. Diabetes. 1990;39:6-11.
48. Cushman S, Wardzala L. Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell. Apparent translocation of intracellular transport systems to the plasma membrane. J Biochem. 1980;255:4728-4762.
49. Bouche C, Serdy S, Kahn CR, Goldfine AB. The cellular fate of glucose and its relevance in type 2 diabetes. Endocr Rev. 2004;25:807-830.
50. Gottesman I, Mandarino L, Gerich J. Use of glucose uptake and glucose clearance for the evaluation of insulin action in vivo. Diabetes. 1984;33:184-191.
51. Rodnick KJ, Piper RC, Slot JW, James DE. Interaction of insulin and exercise on glucose transport in muscle. Diabetes Care. 1992;15:1679-1689.
52. Wright EM. Renal Na(+)-glucose cotransporters. Am J Physiol Renal Physiol. 2001;280:F10-F18.
53. Gerich J. Hepatorenal glucose reciprocity in physiologic and pathologic conditions. Diab Nutr Metab. 2002;15:298-302.
54. Meyer C, Stumvoll M, Nadkarni V, Dostou J, Mitrakou A, Gerich J. Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus. J Clin Invest. 1998;102:619-624.
55. Stumvoll M, Meyer C, Kreider M, Perriello G, Gerich J. Effects of glucagon on renal and hepatic glutamine gluconeogenesis in normal postabsorptive humans. Metabolism. 1998;47:1227-1232.
56. Stumvoll M, Meyer C, Perriello G, Kreider M, Welle S, Gerich J. Human kidney and liver gluconeogenesis: evidence for organ substrate selectivity. Am J Physiol. 1998;274:E817-E826.
57. Cersosimo E, Garlick P, Ferretti J. Renal glucose production during insulin-induced hypoglycemia in humans. Diabetes. 1999;48:261-266.
58. Cersosimo E, Garlick P, Ferretti J. Insulin regulation of renal glucose metabolism in humans. Am J Physiol. 1999;276:E78-E84.
59. Ekberg K, Landau B, Wajngot A, et al. Contributions by kidney and liver to glucose production in the postabsorptive state and after 60 h of fasting. Diabetes. 1999;48:292-298.
60. Cersosimo E, Garlick P, Ferretti J. Regulation of splanchnic and renal substrate supply by insulin in humans. Metabolism. 2000;49:676-683.
61. Cersosimo E, Garlick P, Ferretti J. Renal substrate metabolism and gluconeogenesis during hypoglycemia in humans. Diabetes. 2000;49:1186-1193.
62. Moller N, Rizza R, Ford G, Nair K. Assessment of postabsorptive renal glucose metabolism in humans with multiple glucose tracers. Diabetes. 2001;50:747-751.
63. Meyer C, Dostou J, Welle S, Gerich J. Role of human liver, kidney and skeletal muscle in postprandial glucose homeostasis. Am J Physiol Endocrinol Metab. 2002;282:E419-E427.
64. Garcia-Ruiz J, Moreno F, Sanchez-Medina F, Mayor F. Stimulation of rat kidney phosphoenolpyruvate carboxykinase activity in experimental liver disease induced by galactosamine. FEBS Lett. 1973;34:13-16.
65. Bergman H, Drury DR. The relationship of kidney function to the glucose utilization of the extra abdominal tissues. Am J Physiol. 1938;124:279-284.
66. Drury D, Wick A, MacKay E. Formation of glucose by the kidney. Am J Physiol. 1950;165:655-661.
67. Joseph S, Heaton N, Potter D, Pernet A, Umpleby M, Amiel S. Renal glucose production compensates for the liver during the anhepatic phase of liver transplantation. Diabetes. 2000;49:450-456.
68. Battezzati A, Fattorini A, Caumo A, et al. Non-hepatic glucose production in humans. Diabetes. 1999;48(Suppl 1):A49 (Abstract).
69. Schoolwerth A, Smith B, Culpepper R. Renal gluconeogenesis. Min Electr Metab. 1988;14:347-361.
70. Iles R, Cohen R, Rist A, Baron P. The mechanism of inhibition by acidosis of gluconeogenesis from lactate in rat liver. Biochem J. 1977;164:185-191.
71. Aber G, Morris L, Housley E. Gluconeogenesis by the human kidney. Nature. 1966;212:1589-1590.
72. Gerich J. Hypoglycaemia and counterregulation in type 2 diabetes. Lancet. 2000;356:1946-1947.
73. Meyer C, Dostou J, Gerich J. Role of the human kidney in glucose counterregulation. Diabetes. 1999;48:943-948.
74. Cersosimo E, Garlick P, Ferretti J. Abnormal glucose handling by the kidney in response to hypoglycemia in type 1 diabetes. Diabetes. 2001;50:2087-2093.
75. Woerle HJ, Meyer C, Popa E, Cryer P, Gerich J. Renal compensation for impaired hepatic glucose release during hypoglycemia in type 2 diabetes. Diabetologia. 2001;44(Suppl 1):A67 (Abstract).
76. Stumvoll M, Meyer C, Mitrakou A, Nadkarni V, Gerich J. Renal glucose production and utilization: new aspects in humans. Diabetologia. 1997;40:749-757.
77. Landau B, Wahren J, Chandramouli V, Schuman W, Ekberg K, Kalhan S. Contributions of gluconeogenesis to glucose production in the fasted state. J Clin Invest. 1996;98:378-385.
78. Nilsson L, Hultman E. Liver glycogen in man - the effect of total starvation or a carbohydrate-poor diet followed by refeeding. Scand J Clin Lab Invest. 1973;32:325-330.
79. Perriello G, Jorde R, Nurjhan N, et al. Estimation of the glucose-alanine-lactate-glutamine cycles in postabsorptive man: role of the skeletal muscle. Am J Physiol. 1995;269:E443-E450.
80. McMahon M, Marsh H, Rizza R. Comparison of the pattern of postprandial carbohydrate metabolism after ingestion of a glucose drink or a mixed meal. J Clin Endocrinol Metab. 1989;68:647-653.
81. Dinneen S, Gerich J, Rizza R. Carbohydrate metabolism in noninsulin-dependent diabetes mellitus. N Engl J Med. 1992;327:707-713.
82. Marin P, Hogh-Kristiansen I, Jansson S, Krotkiewski M, Holm G, Bjorntorp P. Uptake of glucose carbon in muscle glycogen and adipose tissue triglycerides in vivo in humans. Am J Physiol. 1992;263:E473-E480.
83. Meyer C, Dostou J, Welle S, Gerich J. Role of liver, kidney and skeletal muscle in the disposition of an oral glucose load. Diabetes. 1999;48(Suppl 1):A289 (Abstract).
84. Kelley D, Mokan M, Veneman T. Impaired postprandial glucose utilization in non-insulin-dependent diabetes mellitus. Metabolism. 1994;43:1549-1557.
85. Butler P, Kryshak E, Rizza R. Mechanism of growth hormone-induced postprandial carbohydrate intolerance in humans. Am J Physiol. 1991;260:E513-E520.
86. Ferrannini E, Bjorkman O, Reichard G, et al. The disposal of an oral glucose load in healthy subjects: a quantitative study. Diabetes. 1985;34:580-588.
87. Jackson R, Roshania R, Hawa M, Sim B, DiSilvio L. Impact of glucose ingestion on hepatic and peripheral glucose metabolism in man: an analysis based on simultaneous use of the forearm and double isotope techniques. J Clin Endocrinol Metab. 1986;63:541-549.
88. McMahon M, Marsh H, Rizza R. Effects of basal insulin supplementation on disposition of a mixed meal in obese patients with NIDDM. Diabetes. 1989;38:291-303.
89. Mitrakou A, Kelley D, Mokan M, et al. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med. 1992;326:22-29.
90. Beckmann N, Fried R, Turkalj I, Seelig J, Keller U, Stalder G. Noninvasive observation of hepatic glycogen formation in man by 13C MRS after oral and intravenous glucose administration. Magn Reson Med. 1993;29:583-590.
91. Petersen K, Cline G, Gerard D, Magnusson I, Rothman D, Shulman G. Contribution of net hepatic glycogen synthesis to disposal of an oral glucose load in humans. Metabolism. 2001;50:598-601.
92. Taylor R, Magnusson I, Rothman D. Direct assessment of liver glycogen storage by 13C nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects. J Clin Invest. 1996;97:126-132.
93. Mitrakou A, Jones R, Okuda Y, et al. Pathway and carbon sources for hepatic glycogen repletion in the dog. Am J Physiol. 1991;260:E194-E202.
94. Firth R, Bell P, Marsh H, Hansen I, Rizza R. Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues. J Clin Invest. 1986;77:1525-1532.
95. Taylor R, Price T, Katz L, Shulman R, Shulman G. Direct measurement of change in muscle glycogen concentration after a mixed meal in normal subjects. Am J Physiol. 1993;265:E224-E229.
96. Radziuk J, Inculet R. The effects of ingested and intravenous glucose on forearm uptake of glucose and glucogenic substrate in normal man. Diabetes. 1983;32:977-981.
97. Ferrannini E, Wahren J, Felig P, DeFronzo R. The role of fractional glucose extraction in the regulation of splanchnic glucose metabolism in normal and diabetic man. Metabolism. 1980;29:28-35.